Literature DB >> 28655198

Glycosylation of IgG-Fc: a molecular perspective.

Masato Kiyoshi1, Kouhei Tsumoto2,3,4, Akiko Ishii-Watabe1, Jose M M Caaveiro5.   

Abstract

Antibodies of the IgG class carry a pair of oligosaccharides (N-glycans) in the Fc region. The importance of the N-glycan is clearly demonstrated by its profound effect in the physicochemical and biological properties of antibodies. The term 'glycoengineering' has been coined to describe contemporary strategies to improve the performance of therapeutic monoclonal antibodies on the basis of modifications in the structure and composition of the N-glycan. These methodologies have resulted in the approval and commercialization of a new generation of antibodies with improved therapeutic efficacy. So far, these advances have been driven by herculean efforts in a process of trial-and-error. The collective work of researchers in this field is progressively revealing the molecular basis of N-glycans for the function of antibodies. This knowledge will ultimately be conducive to the application of rational approaches for the successful manipulation of antibodies using glycoengineering strategies. Herein, we review advances in our understanding of the role of the N-glycan in the structural and dynamic integrity, and biological activity, of antibodies. Since the N-glycan has a multifaceted effect in antibodies, in this review we have emphasized the importance of integrating various techniques that address this problem from multiple points of view. In particular, the combination of X-ray crystallography with nuclear magnetic resonance, molecular dynamics simulations and biophysical approaches based on thermodynamic principles, has emerged as a powerful combination that is deepened our understanding of this unique system with critical implications for human well-being. © The Japanese Society for Immunology. 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  glycoengineering; glycoprotein; protein dynamics; protein structure; therapeutic antibodies

Mesh:

Substances:

Year:  2017        PMID: 28655198     DOI: 10.1093/intimm/dxx038

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  16 in total

1.  Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column.

Authors:  Masato Kiyoshi; Jose M M Caaveiro; Minoru Tada; Hiroko Tamura; Toru Tanaka; Yosuke Terao; Koldo Morante; Akira Harazono; Noritaka Hashii; Hiroko Shibata; Daisuke Kuroda; Satoru Nagatoishi; Seigo Oe; Teruhiko Ide; Kouhei Tsumoto; Akiko Ishii-Watabe
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

Review 2.  Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

Authors:  Wei Li; Zhongyu Zhu; Weizao Chen; Yang Feng; Dimiter S Dimitrov
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

Review 3.  The Essential Functions and Detection of Bisecting GlcNAc in Cell Biology.

Authors:  Qiushi Chen; Zengqi Tan; Feng Guan; Yan Ren
Journal:  Front Chem       Date:  2020-07-03       Impact factor: 5.221

4.  Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.

Authors:  Ryuta Wada; Makoto Matsui; Nana Kawasaki
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

Review 5.  Design and Production of Bispecific Antibodies.

Authors:  Qiong Wang; Yiqun Chen; Jaeyoung Park; Xiao Liu; Yifeng Hu; Tiexin Wang; Kevin McFarland; Michael J Betenbaugh
Journal:  Antibodies (Basel)       Date:  2019-08-02

Review 6.  Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against Cancer.

Authors:  Tae Hyun Kang; Sang Taek Jung
Journal:  Biomolecules       Date:  2020-03-01

7.  The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange.

Authors:  Felix Kuhne; Lea Bonnington; Sebastian Malik; Marco Thomann; Cecile Avenal; Florian Cymer; Harald Wegele; Dietmar Reusch; Michael Mormann; Patrick Bulau
Journal:  Antibodies (Basel)       Date:  2019-10-01

8.  Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis.

Authors:  Katarzyna Sołkiewicz; Hubert Krotkiewski; Marcin Jędryka; Ewa M Kratz
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

9.  Functional production of human antibody by the filamentous fungus Aspergillus oryzae.

Authors:  Hung Hiep Huynh; Naoki Morita; Toshihiro Sakamoto; Takuya Katayama; Takuya Miyakawa; Masaru Tanokura; Yasunori Chiba; Reiko Shinkura; Jun-Ichi Maruyama
Journal:  Fungal Biol Biotechnol       Date:  2020-05-28

10.  Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies.

Authors:  Angelene F Richards; Jennifer E Doering; Shannon A Lozito; John J Varrone; Graham G Willsey; Michael Pauly; Kevin Whaley; Larry Zeitlin; Nicholas J Mantis
Journal:  PLoS Negl Trop Dis       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.